← Open Payments lookup

JEFFREY MONTGOMERY: Open Payments

NPI 1902007990 · CLARKS SUMMIT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,865 in 229 payments from 26 companies in 2025. Trend: 2023 $2,824 · 2024 $2,528 · 2025 $7,865

Consulting: $4,313Food & beverage: $3,552
CompanyPaymentsAmount
ABBVIE INC.51$5,034
Novo Nordisk Inc27$411
AstraZeneca Pharmaceuticals LP10$322
PFIZER INC.25$319
Lilly USA, LLC23$284
Amgen Inc.8$215
Bayer Healthcare Pharmaceuticals Inc.12$196
Boehringer Ingelheim Pharmaceuticals, Inc.14$184
Kowa Pharmaceuticals America, Inc.14$167
Aimmune Therapeutics, Inc.9$135

Products named: QULIPTA, UBRELVY, JARDIANCE, AIRSUPRA, VRAYLAR, Ozempic, Kerendia, NURTEC ODT.

Industry payments across PA — which companies pay providers there.